OPKO Health Inc OPK:NASDAQ

Last Price$1.90NASDAQ Previous Close - Last Trade as of 4:00PM ET 6/14/19

Today's Change0(0.00%)
Bid (Size)$1.90 (497)
Ask (Size)$1.91 (448)
Day Low / HighN/A - N/A
Volume2.5 M
 

View Biotechnology IndustryPeer Comparison as of 06/14/2019

 

OPKO Health Inc ( NASDAQ )

Price: $1.90
Change: -0.05 (2.56%)
Volume: 2.5 M
4:00PM ET 6/14/2019
 
 

N/A ( N/A )

Price: N/A
Change: N/A N/A
Volume: N/A
N/A
 
 

Fate Therapeutics Inc ( NASDAQ )

Price: $17.83
Change: +0.25 (1.42%)
Volume: 986.9 K
4:00PM ET 6/14/2019
 
 

Momenta Pharmaceuticals Inc ( NASDAQ )

Price: $11.98
Change: -0.16 (1.32%)
Volume: 394.1 K
4:00PM ET 6/14/2019
 
 

Eidos Therapeutics Inc ( NASDAQ )

Price: $31.41
Change: -0.07 (0.22%)
Volume: 134.1 K
4:00PM ET 6/14/2019
 

Read more news Recent News

Patient Data for OPKO Health Subsidiary Possibly Hit in Cyberattack
10:50AM ET 6/06/2019 MT Newswires

BioReference Laboratories, an OPKO Health (OPK) subsidiary, may have had its patient data compromised by a hack on its former collection agency's website,...

Insider Trends: OPKO Health Insider 90-Day Buying Trend Added to with Purchase
6:07AM ET 6/06/2019 MT Newswires

Dr Phillip Frost, 10% Owner, Director and CEO & Chairman, on Jun 05, 2019, made a purchase of 150,000 shares in OPKO Health (OPK) for $288,201. Following...

Insider Trends: Insider Purchase of OPKO Health Stock Continues 90-Day Positive Trend
6:14AM ET 6/03/2019 MT Newswires

Dr Phillip Frost, 10% Owner, Director and CEO & Chairman, purchased 100,000 shares in OPKO Health (OPK) for $176,421 on May 31, 2019. Following the Form 4...

Insider Trends: Insider Purchase of OPKO Health Stock Extends 90-Day Positive Trend
6:51AM ET 5/30/2019 MT Newswires

Dr Phillip Frost, 10% Owner, Director and CEO & Chairman, executed a purchase for 70,000 shares of OPKO Health (OPK) on May 29, 2019, for $128,970. ...

View all Commentary and Analysis

Stoke Therapeutics Files Proposed Terms For IPO
12:24PM ET 6/11/2019 Seeking Alpha

Portfolio Composition: Short Commodity, Precious Metals; Long Rare Earths, Biotech
3:35AM ET 6/11/2019 Seeking Alpha

Daily Insider Ratings Round Up 5/29/19
1:20PM ET 5/31/2019 Seeking Alpha

Top 5 Market Movers With Insider Buying As Of May 24, 2019
2:46AM ET 5/28/2019 Seeking Alpha

Company Profile

Business DescriptionOPKO Health, Inc. engages in the provision of healthcare services. It operates through the Diagnostics and Pharmaceuticals segments. The Diagnostics segment comprises clinical laboratory operations which acquired through the Bio-Reference and point-of-care operations. The Pharmaceuticals segment includes the pharmaceutical operations acquired in Chile, Mexico, Ireland, Israel, and Spain; and pharmaceutical research and development operations. The company was founded in October 1991 and is headquartered in Miami, FL. View company web site for more details
Address4400 Biscayne Boulevard
Miami, Florida 33137
Phone+1.305.575.4100
Number of Employees5,690
Recent SEC Filing06/14/20194
Chairman & Chief Executive OfficerPhillip Frost
Chief Financial & Accounting Officer, Senior VPAdam E. Logal
Vice Chairman & Chief Technology OfficerJane H. Hsiao
Director & Executive Vice President-AdministrationSteven D. Rubin

Company Highlights

Price Open$1.93
Previous Close$1.95
52 Week Range$1.73 - 6.40
Market Capitalization$1.2 B
Shares Outstanding615.6 M
SectorHealth Technology
IndustryBiotechnology
Next Earnings Announcement08/06/2019

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$0.33
Beta vs. S&P 500N/A
Revenue$990.3 M
Net Profit Margin-19.91%
Return on Equity-10.66%

Analyst Ratings as of 06/07/2019

Buy
3
Overweight
0
Hold
0
Underweight
0
Sell
0
Consensus RecommendationConsensus Icon
Powered by Factset